Genmab A (GMAB) Inventory (2023 - 2025)
Historic Inventory for Genmab A (GMAB) over the last 3 years, with Q4 2025 value amounting to $18.0 million.
- Genmab A's Inventory rose 10000.0% to $18.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $18.0 million, marking a year-over-year increase of 10000.0%. This contributed to the annual value of $18.0 million for FY2025, which is 10000.0% up from last year.
- Latest data reveals that Genmab A reported Inventory of $18.0 million as of Q4 2025, which was up 10000.0% from $14.0 million recorded in Q3 2025.
- In the past 5 years, Genmab A's Inventory ranged from a high of $18.0 million in Q4 2025 and a low of -$8.0 million during Q4 2023
- Over the past 3 years, Genmab A's median Inventory value was $9.0 million (recorded in 2024), while the average stood at $5.8 million.
- Over the last 5 years, Genmab A's Inventory had its largest YoY gain of 80000.0% in 2025, and its largest YoY loss of 10000.0% in 2025.
- Over the past 3 years, Genmab A's Inventory (Quarter) stood at -$8.0 million in 2023, then surged by 212.5% to $9.0 million in 2024, then surged by 100.0% to $18.0 million in 2025.
- Its last three reported values are $18.0 million in Q4 2025, $14.0 million for Q3 2025, and $13.0 million during Q2 2025.